Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ROCKET PHARMACEUTICALS, INC. | Director, Other*, 10%+ Owner | Common Stock | 18.2M | $494M | $27.20 | Aug 28, 2023 | Indirect |
ROCKET PHARMACEUTICALS, INC. | Director, Other*, 10%+ Owner | Common Stock, $0.01 par value ("Common Stock") | 18.7M | $411M | $22.05 | Aug 28, 2023 | Indirect |
Orchestra BioMed Holdings, Inc. | 10%+ Owner | Common Stock | 5.62M | $90.2M | $16.04 | Apr 13, 2023 | Indirect |
CARGO Therapeutics, Inc. | 10%+ Owner | Common stock, par value $0.001 per share | 5.18M | $77.6M | $15.00 | Nov 14, 2023 | Indirect |
Avidity Biosciences, Inc. | 10%+ Owner | Common Stock | 4.8M | $48.6M | $10.13 | Aug 4, 2021 | By RTW |
Tarsus Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 2.01M | $40.3M | $20.00 | May 7, 2021 | By RTW |
Milestone Pharmaceuticals Inc. | 10%+ Owner | Common Shares, no par value ("Common Shares") | 3.26M | $28.4M | $8.71 | Mar 22, 2023 | Indirect |
DermTech, Inc. | 10%+ Owner | Common Stock | 3.02M | $4.53M | $1.50 | Nov 4, 2022 | Indirect |
Landos Biopharma, Inc. | 10%+ Owner | Common Stock | 3.98M | $2.74M | $0.69 | Sep 23, 2022 | Indirect |
CARGO Therapeutics, Inc. | 10%+ Owner | Common stock, par value $0.001 per share ("Common Stock") | 5.18M | Jan 12, 2024 | Indirect | ||
ROCKET PHARMACEUTICALS, INC. | Director, Other*, 10%+ Owner | Pre-funded Warrant (right to buy) | 3.13M | Sep 15, 2023 | Indirect | ||
Avidity Biosciences, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | Jun 11, 2020 | By RTW | ||
DermTech, Inc. | 10%+ Owner | Warrants to Purchase Common Stock | 0 | $9.54 | Jan 26, 2021 | Indirect | |
Renovacor, Inc. | Other*, 10%+ Owner | Common Stock, par value $0.0001 per share ("Common Stock") | 0 | $8.00 | Dec 1, 2022 | Indirect | |
Renovacor, Inc. | Other*, 10%+ Owner | Warrant | 0 | Dec 1, 2022 | Indirect | ||
ROCKET PHARMACEUTICALS, INC. | Director, Other*, 10%+ Owner | Equity Swap (obligation to buy) | 0 | Aug 28, 2023 | Indirect | ||
ROCKET PHARMACEUTICALS, INC. | Director, Other*, 10%+ Owner | Equity Swap (obligation to sell) | 0 | Aug 28, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRGX | CARGO Therapeutics, Inc. | Jan 12, 2024 | 1 | $0 | 4 | Jan 16, 2024 | 10%+ Owner |
CRGX | CARGO Therapeutics, Inc. | Nov 14, 2023 | 0 | $0 | 3 | Nov 24, 2023 | 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Sep 15, 2023 | 1 | $50M | 4 | Sep 19, 2023 | Director, Other*, 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Aug 28, 2023 | 6 | $0 | 4 | Aug 30, 2023 | Director, Other*, 10%+ Owner |
OBIO | Orchestra BioMed Holdings, Inc. | Apr 13, 2023 | 1 | $0 | 4 | May 5, 2023 | 10%+ Owner |
MIST | Milestone Pharmaceuticals Inc. | Mar 22, 2023 | 1 | $0 | 4 | Mar 24, 2023 | 10%+ Owner |
OBIO | Orchestra BioMed Holdings, Inc. | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | 10%+ Owner |
OBIO | Health Sciences Acquisitions Corp 2 | Jan 24, 2023 | 0 | $0 | 3 | Jan 26, 2023 | 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Dec 23, 2022 | 1 | $0 | 4 | Dec 23, 2022 | Other*, 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Dec 22, 2022 | 1 | $0 | 4 | Dec 22, 2022 | Director, Other*, 10%+ Owner |
RCOR | Renovacor, Inc. | Dec 1, 2022 | 2 | $0 | 4 | Apr 5, 2023 | Other*, 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Oct 6, 2022 | 1 | $20M | 4 | Oct 11, 2022 | Director, Other*, 10%+ Owner |
LABP | Landos Biopharma, Inc. | Sep 23, 2022 | 1 | -$207K | 4 | Sep 27, 2022 | 10%+ Owner |
MIST | Milestone Pharmaceuticals Inc. | Sep 7, 2022 | 2 | $0 | 4 | Sep 9, 2022 | 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | May 19, 2022 | 3 | $0 | 4 | Apr 5, 2023 | Other*, 10%+ Owner |
RCOR | Renovacor, Inc. | Jan 18, 2022 | 1 | $356K | 4 | Jan 20, 2022 | 10%+ Owner |
RCOR | Renovacor, Inc. | Jan 12, 2022 | 4 | $1.22M | 4 | Jan 14, 2022 | 10%+ Owner |
RCOR | Renovacor, Inc. | Jan 4, 2022 | 3 | $1.21M | 4 | Jan 6, 2022 | 10%+ Owner |
RCOR | Renovacor, Inc. | Dec 29, 2021 | 3 | $37.3K | 4 | Jan 3, 2022 | 10%+ Owner |
RCOR | Renovacor, Inc. | Dec 23, 2021 | 2 | $530K | 4 | Dec 28, 2021 | 10%+ Owner |
RCOR | Renovacor, Inc. | Dec 20, 2021 | 5 | $1.11M | 4 | Dec 22, 2021 | 10%+ Owner |
RCOR | Renovacor, Inc. | Nov 15, 2021 | 4 | $611K | 4 | Nov 17, 2021 | 10%+ Owner |
RCOR | Renovacor, Inc. | Nov 9, 2021 | 3 | $81.9K | 4 | Nov 12, 2021 | 10%+ Owner |
RCOR | Renovacor, Inc. | Nov 4, 2021 | 4 | $1.41M | 4 | Nov 8, 2021 | 10%+ Owner |
RCOR | Renovacor, Inc. | Sep 2, 2021 | 1 | $8M | 4 | Sep 7, 2021 | 10%+ Owner |
RNA | Avidity Biosciences, Inc. | Aug 4, 2021 | 2 | $14.4M | 4 | Aug 6, 2021 | 10%+ Owner |
CHAQ | Chardan Healthcare Acquisition 2 Corp. | Jul 22, 2021 | 0 | $0 | 3 | Jul 29, 2021 | 10%+ Owner |
MIST | Milestone Pharmaceuticals Inc. | May 21, 2021 | 1 | $4.99M | 4 | May 24, 2021 | 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | May 11, 2021 | 2 | -$29M | 4 | May 13, 2021 | Director, 10%+ Owner |
TARS | Tarsus Pharmaceuticals, Inc. | May 7, 2021 | 1 | -$13.5M | 4 | May 7, 2021 | 10%+ Owner |
DMTK | DermTech, Inc. | Jan 26, 2021 | 3 | -$177K | 4 | Nov 8, 2022 | 10%+ Owner |